Seragon Biosciences launched a new longevity-optimizing product, Enlivien, which neutralizes harmful, reactive molecules in the gut that have been tied to sleep deprivation.

Scientists develop a new brain aging clock based on gene expression patterns in brain tissue from 778 individuals and apply it to identify drugs that rejuvenate the brain in aged mice.

Osteoporosis — age-related bone loss — is prevented by removing (senescent) cells that promote the accumulation of Alzheimer’s proteins in old mice.

Biologist Brian Kennedy joins Peter Attia to discuss rapamycin trials, aging models, biological clocks, and lifestyle tools that may extend human healthspan.

An HIV medication, maraviroc, increases muscle size, grip strength, running speed, and running distance in aged mice.

Columbia University scientists find that inflammation increases the risk of common chronic age-related diseases only in people from industrialized populations.

New research suggests that consuming tocotrienol—a form of vitamin E—improves markers of aging in human subjects.

New research shows low-dose psilocybin extends cellular lifespan by up to 57%, preserves telomeres, reduces senescence, and boosts survival in aged mice.

A new study reveals the supplements taken by centenarians — people who live to be 100 years or older.

New research reveals that small vesicles derived from human umbilical cord cells, when infused with NMN (nicotinamide mononucleotide), delay skin aging in a mouse model.

Aging encompasses a gradual decline in cellular and physiological function, and some potential strategies, such as NAD+ precursors and rapamycin, may help address this decline.

Apigenin, a natural compound found in plants like chamomile, prevents muscle loss in obese middle-aged rats.

These supplements can mimic the health and longevity benefits of calorie restriction, offering a promising avenue for healthy aging without dietary limitations.

Researchers from the National Institute on Aging (NIA) ran large-scale statistical analyses, which suggested that the GrimAge epigenetic aging clock outperforms other epigenetic aging clocks in predicting mortality.

Monoclonal antibodies, already in clinical use, show promise against drivers of cellular aging, including senescent cells and inflammation.